T-cell engaging antibodies: what lessons have we learnt?
CLL therapy - current status and issues
Escalating doses and improving outcomes in cutaneous T-cell lymphomas
Highlights from the 2016 European Multiple Myeloma Academy (EMMA) and overview of EMMA 2017
Jesús San Miguel
Patient-physician communication: what can be improved?